תבנית:תרופה/לוסרטה 50 - Losarta 50: הבדלים בין גרסאות

|קבוצה פרמקולוגית (ATC)=

{{ATC משרד הבריאות|C09CA|Angiotensin II antagonists, plain}}

|התוויה={{{התוויה|<div style="direction:ltr;">Hypertension: Losarta 50 mg is indicated for the treatment of hypertensionHeart failure: Losarta 50 mg is indicated for the treatment of heart failure, usually in addition to diuretics and/or digitalis, if use of an ACE inhibitor is not appropriate.Switching patients with heart failure who are stable on an ACE inhibitor to Losarta 50 mg is not recommended.Renal protection in Type-2 diabetic patients with proteinuria: Losarta 50 mg is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine, end stage renal disease (need for dialysis or renal transplantation) or death; and to reduce proteinuria.Reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. Losarta 50 mg is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death, stroke, and myocardial infarction in hypertensive patients with left ventricular hypertrophy.The benefit of Losarta 50 mg on the primary deposite endpoint was largely driven by reduction in the risk of stroke.</div>}}}

 

|קישור למאגר משרד הבריאות1=[https://data.health.gov.il/drugs/index.html#!/medDetails/139%2093%2031578%2000 לוסרטה 50] במאגר משרד הבריאות

|עלון לרופא={{רווח קשיח}}